Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: Frequency of occurrence and antimicrobial susceptibility profile: Results from the SENTRY Antimicrobial Surveillance Program (1997-2000)

Diagnostic Microbiology and Infectious Disease

Volumn 44, Issue 3, 2002, Pages 301-311

  Gales, Ana C ^a   Sader, Hélio S ^a   Jones, Ronald N ^b,c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b JMI LABORATORIES   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEPHALOSPORIN DERIVATIVE; DALFOPRISTIN; LINEZOLID; MEROPENEM; METICILLIN; PIPERACILLIN; QUINUPRISTIN; TAZOBACTAM; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RESEARCH; DRUG SURVEILLANCE PROGRAM; EMPIRICISM; ENTEROBACTER; ESCHERICHIA COLI; FERMENTATION; GRAM NEGATIVE BACTERIUM; HOSPITALIZATION; IN VITRO STUDY; ISOLATION PROCEDURE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; SOUTH AND CENTRAL AMERICA; STAPHYLOCOCCUS AUREUS; TIME;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE COCCI; HOSPITALIZATION; HUMANS; LATIN AMERICA; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL; PREVALENCE; RESPIRATORY TRACT INFECTIONS; SENTINEL SURVEILLANCE;

EID: 0036864727     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00499-6     Document Type: Article

References (39)

1. Hospital-acquired pneumonia in adults diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies . Am J Respir Crit Care Med. 153:1995;1711-1725.
2. Baraibar J., Correa H., Mariscal D., Gallego M., Valles J., Rello J. Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia. Chest. 112:1997;1050-1054.
3. Bauernfeind A., Casellas J.M., Goldberg M., Holley M., Jungwirth R., Mangold P., et al. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection. 20:1992;158-163.
4. Bush K., Jacoby G.A., Medeiros A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 39:1995;1211-1233.
5. Guidelines for prevention of nosocomial pneumonia. MMWR. 46:1997;6-7.
6. Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. MMWR. 46:1997;765-766.
7. Diekema D.J., Pfaller M.A., Schmitz F.J., Smayevsky J., Bell J., Jones R.N., Beach M. Survey of infections due to Staphylococcus species frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999 . Clin Infect Dis. 32:(Suppl 2):2001;S114-132.
8. Forster D.H., Daschner F.D. Acinetobacter species as nosocomial pathogens. Eur J Clin Microbiol Infect Dis. 17:1998;73-77.
9. Gales A.C., Jones R.N., Forward K.R., Liñares J., Sader H.S., Verhoef J. Emerging importance of multidrug-resistant Acinetobacter spp. and Stenotrophomonas maltophilia as pathogens in seriously ill patients geographic patterns, epidemiologic features and trends from the SENTRY Antimicrobial Surveillance Program (1997-99) . Clin Infect Dis. 32:(Suppl 2):2001;104-113.
10. Gales A.C., Jones R.N., Turnridge J., Rennie R., Ramphal R. Characterization of Pseudomonas aeruginosa ocurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999 . Clin Infect Dis. 32:(Suppl 2):2001;S146-155.
11. th Interscience Conference on Antimicrobial Agents and Chemotherapy. P. 170. Abstract 1487. San Francisco, September 26-29.
12. Garibaldi R.A. Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. Am J Med. 78:1985;32-37.
13. Hiramatsu K. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan. Am J Med. 104:(Suppl 5A):1998;7-10.
14. Jones R.N., Croco M.A., Kugler K.C., Pfaller M.A., Beach M.L. Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) . Diagn Microbiol Infect Dis. 3:2000;115-125.
15. Kollef M.H., Silver P., Murphy D.M., Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest. 108:1995;1655-1662.
16. Leu H.S., Kaiser D.L., Mori M., Woolson R.F., Wenzel R.P. Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol. 129:1989;1258-1267.
17. Lewis M.T., Gales A.C., Sader H.S., Pfaller M.A., Jones R.N. Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from Latin American patients with a diagnosis of pneumonia Results form the SENTRY antimicrobial surveillance program (1998) . Diagn Microbiol Infect Dis. 37:2000;63-74.
18. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa our worst nightmare . Clin Infect Dis. 34:2002;634-640.
19. Lynch J.P., Niederman M.S. Controversies in respiratory infections. Semin Respir Infect. 12:1997;69-270.
20. Mandell L.A., Campbell G.D. Jr. Nosocomial pneumonia guidelines. An international perspective. Chest. 113:1998;188S-193S.
21. Marston B.J., Plouffe J.F., File T.M. Jr., Hackman B.A., Salstrom S.J., Lipman H.B., Kolczak M.S., Breiman R.F. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med. 157:1997;1709-1718.
22. Mathai D., Lewis M.T., Kugler K.C., Pfaller M.A., Jones R.N. Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia I-results from the SENTRY Antimicrobial Surveillance Program (North America, 1998) . Diagn Microbiol Infect Dis. 39:2001;105-116.
23. McDonald L.C., Banerjee S.N., Jarvis W.R. Seasonal variation of Acinetobacter infections 1987-1996. Nosocomial Infections Surveillance System . Clin Infect Dis. 29:1999;1133-1137.
24. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, fourth edition. Approved standard M7-A5. National Committee for Clinical Laboratory Standards. 2000;NCCLS, Wayne, PA.
25. Performance standard for antimicrobial susceptibility testing. Document M100-S12. 2002;NCCLS, Wayne, PA.
26. National Nosocomial Infections Surveillance (NNIS) Report, Dta Summary from October 1986-April 1996, Issued May 1996. (1996). Am J Infect Control, 24, 380-388.
27. National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001. (2001). Am J Infect Control, 29, 404-421.
28. Niederman M.S., McCombs J.S., Unger A.N., Kumar A., Popovian R. The cost of treating community-acquired pneumonia. Clin Ther. 20:1998;820-837.
29. Oliveira G.A., Dell'Aquila A.M., Masiero R.L., Levy C.E., Gomes M.S., Cui L., Hiramatsu K., Mamizuka E.M. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infect Control Hosp Epidemiol. 22:2001;443-448.
30. Rello J., Ricart M., Ausina V., Net A., Prats G. Pneumonia due to Haemophilus influenzae among mechanically ventilated patients incidence, outcome, and risks factors . Chest. 102:1992;1562-1565.
31. Richards M.J., Edwards J.R., Culver D.H., Gaynes R.P. Nosocomial Infections in medical intensive care units in the United States. Crit Care Med. 27:1999;887-892.
32. Sader H.S., Gales A.C. Emerging Strategies in infectious Diseases Carbapenems and trinems in development . Drugs. 61:2001;553-564.
33. Sader H.S., Pfaller M.A., Jones R.N., Doern G.V., Gales A.C., Winokur P.L., Kugler K.C. Bacterial Pathogens Isolated from Patients with Bloodstream Infections in Latin America, 1997 Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program . Braz J Infect Dis. 3:1999;97-110.
34. Schleupner C.J., Cobb D.K. A study of the etiologies and treatment of nosocomial pneumonia in a community-based teaching hospital. Infect Control Hosp Epidemiol. 13:1992;515-525.
35. Struelens M.J., Carlier E., Maes N., Serruys E., Quint W.G., van Belkum A. Nosocomial colonization and infection with multiresistant Acinetobacter baumannii outbreak delineation using DNA macrorestriction analysis and polymerase chain reaction-fingerprinting . J Hosp Infect. 25:1993;15-32.
36. Talon D., Mulin B., Rouget C., Bailly P., Thouverez M., Viel J.F. Risks and routes for ventilator-associated pneumonia with Pseudomonas aeruginosa. Am J Respir Crit Care Med. 157:1998;978-984.
37. Torres A., Aznar R., Gatell J.M., Jimenez P., Gonzales J. Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Resp Dis. 142:1990;523-528.
38. Winokur P.L., Canton R., Casellas J.M., Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis. 32:(Suppl 2):2001;94-103.
39. Causes of annual death worldwide-1998. 1998;World Heath Organization, Geneva.